Pfizer Shares Dropped to Their Lowest Level in Over 10 Years—Here's Why

3
Comment
Favorite

Pfizer Shares Dropped to Their Lowest Level in Over 10 Years—Here's Why

Investopedia2023-12-14

Trending VideosKey TakeawaysPfizer gave 2024 profit and revenue guidance below estimates as demand declines for its COVID-19 products.The drug maker projects 2024 COVID-19 vaccines and treatments will...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2391602325?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-12-14 10:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2391602325","market":"us","top_or_hot":-1,"title":"Pfizer Shares Dropped to Their Lowest Level in Over 10 Years—Here's Why","media":"Investopedia","content":"<div>\n<p>Trending VideosKey TakeawaysPfizer gave 2024 profit and revenue guidance below estimates as demand declines for its COVID-19 products.The drug maker projects 2024 COVID-19 vaccines and treatments will...</p>\n\n<a href=\"https://www.investopedia.com/pfizer-shares-dropped-to-their-lowest-level-in-over-10-years-here-is-why-8415271?utm_campaign=quote-yahoo&utm_source=yahoo&utm_medium=referral&yptr=yahoo\">Source Link</a>\n\n</div>\n","source":"yahoofinance_sg","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shares Dropped to Their Lowest Level in Over 10 Years—Here's Why</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shares Dropped to Their Lowest Level in Over 10 Years—Here's Why\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-12-14 10:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investopedia.com/pfizer-shares-dropped-to-their-lowest-level-in-over-10-years-here-is-why-8415271?utm_campaign=quote-yahoo&utm_source=yahoo&utm_medium=referral&yptr=yahoo><strong>Investopedia</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Trending VideosKey TakeawaysPfizer gave 2024 profit and revenue guidance below estimates as demand declines for its COVID-19 products.The drug maker projects 2024 COVID-19 vaccines and treatments will...</p>\n\n<a href=\"https://www.investopedia.com/pfizer-shares-dropped-to-their-lowest-level-in-over-10-years-here-is-why-8415271?utm_campaign=quote-yahoo&utm_source=yahoo&utm_medium=referral&yptr=yahoo\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00BLSP4239.USD","symbol_name":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","start_time":0,"source_url":"https://www.investopedia.com/pfizer-shares-dropped-to-their-lowest-level-in-over-10-years-here-is-why-8415271?utm_campaign=quote-yahoo&utm_source=yahoo&utm_medium=referral&yptr=yahoo","article_id":"2391602325","we_media_id":null,"thumbnails":[],"rights":{"source":"yahoofinance_sg","url":"https://www.investopedia.com/pfizer-shares-dropped-to-their-lowest-level-in-over-10-years-here-is-why-8415271?utm_campaign=quote-yahoo&utm_source=yahoo&utm_medium=referral&yptr=yahoo","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2391602325","pubTimestamp":1702522484,"sourceInfo":{"source_id":"yahoofinance_sg","name":"Yahoo Finance"},"weMediaInfo":null,"summary":"Trending VideosKey TakeawaysPfizer gave 2024 profit and revenue guidance below estimates as demand declines for its COVID-19 products.The drug maker projects 2024 COVID-19 vaccines and treatments will","collect":0,"end_time":0,"defaultTopTitle":"investopedia.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","BK4551":"寇图资本持仓","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","BK4581":"高盛持仓","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","BK4548":"巴美列捷福持仓","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","BK4588":"碎股","SG9999002232.USD":"Allianz Global High Payout USD","LU0234572021.USD":"高盛美国核心股票组合Acc","SG9999002224.SGD":"Allianz Global High Payout SGD","LU0058720904.USD":"联博国际健康护理基金A","BK4592":"伊斯兰概念","BK4550":"红杉资本持仓","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","BK4534":"瑞士信贷持仓","BK4585":"ETF&股票定投概念","BK4139":"生物科技","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","LU0122379950.USD":"贝莱德世界健康科学A2","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","PFE":"辉瑞","BK4535":"淡马锡持仓","SG9999001176.USD":"United Global Healthcare Acc USD","BK4568":"美国抗疫概念"},"translate_title":"辉瑞股价跌至10年来的最低点——原因如下","themeId":"c5bbfdf5f7964880af97c1d6f417052c","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":1},"content_text":"Trending VideosKey TakeawaysPfizer gave 2024 profit and revenue guidance below estimates as demand declines for its COVID-19 products.The drug maker projects 2024 COVID-19 vaccines and treatments will generate sales of $8 billon, compared to $12.5 billion this year.Pfizer shares tumbled to their lowest level since 2013.Pfizer (PFE) shares tumbled over 6% on Wednesday to their lowest level in more than 10 years after warning revenue could decline next year and releasing guidance below forecasts as demand for its COVID-19 vaccines and treatments wanes.The drug maker indicated it expects 2024 revenue to be in a range of $58.5 billion to $61.5 billion, up slightly from this year’s outlook of $58 billion to $61 billion. It projects profit of $2.05 to $2.25 per share. Both were short of estimates. Pfizer indicated that its COVID-19 shot and Paxlovid treatment for the virus will generate $8 billion in sales next year, versus the approximately $12.5 billion it expects to make on those products this year.CFO David Denton told analysts the company doesn’t anticipate COVID-19 vaccination rates in 2024 will be significantly different from 2023, and CEO Albert Bourla added that Pfizer wanted to create a “good floor” so as to avoid overestimating demand, as it did this year. The pharmaceutical firm noted it projects $3.1 billion in 2024 sales from its $43 billion acquisition of cancer drug maker Seagen in February. That deal was approved by U.S. regulators this week, and Pfizer expects it to close tomorrow.Shares of Pfizer have lost close to half their value this year.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":3,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}